ID   MELK_HUMAN              Reviewed;         651 AA.
AC   Q14680; B1AMQ6; Q7L3C3;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 3.
DT   05-OCT-2010, entry version 98.
DE   RecName: Full=Maternal embryonic leucine zipper kinase;
DE            Short=hMELK;
DE            EC=2.7.11.1;
DE   AltName: Full=Protein kinase PK38;
DE            Short=hPK38;
GN   Name=MELK; Synonyms=KIAA0175;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Bone marrow;
RX   MEDLINE=96281124; PubMed=8724849; DOI=10.1093/dnares/3.1.17;
RA   Nagase T., Seki N., Ishikawa K., Tanaka A., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. V.
RT   The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by
RT   analysis of cDNA clones from human cell line KG-1.";
RL   DNA Res. 3:17-24(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH ZNF622, AND FUNCTION IN PHOSPHORYLATION OF ZNF622.
RC   TISSUE=Keratinocyte;
RX   PubMed=11802789; DOI=10.1042/0264-6021:3610597;
RA   Seong H.-A., Gil M., Kim K.-T., Kim S.-J., Ha H.;
RT   "Phosphorylation of a novel zinc-finger-like protein, ZPR9, by murine
RT   protein serine/threonine kinase 38 (MPK38).";
RL   Biochem. J. 361:597-604(2002).
RN   [6]
RP   INTERACTION WITH PPP1R8, AUTOPHOSPHORYLATION, MUTAGENESIS OF ASP-150;
RP   THR-345; THR-387; THR-409; THR-415; THR-428; THR-446; THR-460;
RP   THR-466; THR-478 AND THR-518, PHOSPHORYLATION AT THR-478, AND
RP   FUNCTION.
RX   PubMed=14699119; DOI=10.1074/jbc.M311466200;
RA   Vulsteke V., Beullens M., Boudrez A., Keppens S., Van Eynde A.,
RA   Rider M.H., Stalmans W., Bollen M.;
RT   "Inhibition of spliceosome assembly by the cell cycle-regulated
RT   protein kinase MELK and involvement of splicing factor NIPP1.";
RL   J. Biol. Chem. 279:8642-8647(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-505, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356; THR-446; THR-460;
RP   THR-478; THR-494; SER-498; SER-505; THR-518 AND SER-529, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-431 AND SER-505, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-335; SER-356; THR-460;
RP   SER-498; SER-505; THR-518 AND SER-529, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] MET-56; ARG-219; LYS-333; ILE-348 AND
RP   MET-460.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Phosphorylates ZNF622 and may contribute to its
CC       redirection to the nucleus. May be involved in the inhibition of
CC       spliceosome assembly during mitosis.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Interacts with ZNF622 and PPP1R8.
CC   -!- INTERACTION:
CC       Q9BZR8:BCL2L14; NbExp=3; IntAct=EBI-1046702, EBI-1385773;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (Potential).
CC   -!- TISSUE SPECIFICITY: Expressed in placenta, kidney, thymus, testis,
CC       ovary and intestine.
CC   -!- PTM: Autophosphorylated. Thr-478 phosphorylation during mitosis
CC       promotes interaction with PPP1R8 (Probable).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. SNF1 subfamily.
CC   -!- SIMILARITY: Contains 1 KA1 (kinase-associated) domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA11492.2; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D79997; BAA11492.2; ALT_INIT; mRNA.
DR   EMBL; AL354932; CAI11034.2; -; Genomic_DNA.
DR   EMBL; AL442063; CAI11034.2; JOINED; Genomic_DNA.
DR   EMBL; AL442063; CAI16995.2; -; Genomic_DNA.
DR   EMBL; AL354932; CAI16995.2; JOINED; Genomic_DNA.
DR   EMBL; CH471071; EAW58303.1; -; Genomic_DNA.
DR   EMBL; BC014039; AAH14039.1; -; mRNA.
DR   IPI; IPI00006471; -.
DR   RefSeq; NP_055606.1; -.
DR   UniGene; Hs.184339; -.
DR   ProteinModelPortal; Q14680; -.
DR   SMR; Q14680; 9-320, 553-651.
DR   IntAct; Q14680; 9.
DR   STRING; Q14680; -.
DR   PhosphoSite; Q14680; -.
DR   PRIDE; Q14680; -.
DR   Ensembl; ENST00000298048; ENSP00000298048; ENSG00000165304.
DR   GeneID; 9833; -.
DR   KEGG; hsa:9833; -.
DR   UCSC; uc003zzn.1; human.
DR   CTD; 9833; -.
DR   GeneCards; GC09P036562; -.
DR   H-InvDB; HIX0008033; -.
DR   HGNC; HGNC:16870; MELK.
DR   HPA; HPA017214; -.
DR   MIM; 607025; gene.
DR   PharmGKB; PA134902874; -.
DR   eggNOG; prNOG13861; -.
DR   HOGENOM; HBG383890; -.
DR   HOVERGEN; HBG106273; -.
DR   InParanoid; Q14680; -.
DR   OMA; QTMEDLI; -.
DR   OrthoDB; EOG95MQS0; -.
DR   PhylomeDB; Q14680; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 37054; -.
DR   ArrayExpress; Q14680; -.
DR   Bgee; Q14680; -.
DR   CleanEx; HS_MELK; -.
DR   Genevestigator; Q14680; -.
DR   GermOnline; ENSG00000165304; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   InterPro; IPR020636; Ca/CaM-dep_prot_kinase-like.
DR   InterPro; IPR001772; Kinase-assoc_KA1.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR015739; Melk_kinase.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   PANTHER; PTHR22982; Ca/CaM-dep_prot_kinase-like; 1.
DR   PANTHER; PTHR22982:SF57; Melk_kinase; 1.
DR   Pfam; PF02149; KA1; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50032; KA1; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Cytoplasm; Kinase; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    651       Maternal embryonic leucine zipper kinase.
FT                                /FTId=PRO_0000086323.
FT   DOMAIN       11    263       Protein kinase.
FT   DOMAIN      602    651       KA1.
FT   NP_BIND      17     25       ATP (By similarity).
FT   ACT_SITE    132    132       Proton acceptor (By similarity).
FT   BINDING      40     40       ATP (By similarity).
FT   MOD_RES     335    335       Phosphoserine.
FT   MOD_RES     356    356       Phosphoserine.
FT   MOD_RES     431    431       Phosphoserine.
FT   MOD_RES     446    446       Phosphothreonine.
FT   MOD_RES     460    460       Phosphothreonine.
FT   MOD_RES     478    478       Phosphothreonine.
FT   MOD_RES     494    494       Phosphothreonine.
FT   MOD_RES     498    498       Phosphoserine.
FT   MOD_RES     505    505       Phosphoserine.
FT   MOD_RES     518    518       Phosphothreonine.
FT   MOD_RES     529    529       Phosphoserine.
FT   VARIANT      56     56       T -> M (in dbSNP:rs35233455).
FT                                /FTId=VAR_040794.
FT   VARIANT     219    219       K -> R (in dbSNP:rs35142210).
FT                                /FTId=VAR_040795.
FT   VARIANT     333    333       R -> K (in dbSNP:rs34655121).
FT                                /FTId=VAR_040796.
FT   VARIANT     348    348       T -> I (in dbSNP:rs55845414).
FT                                /FTId=VAR_040797.
FT   VARIANT     460    460       T -> M (in an ovarian mucinous carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040798.
FT   MUTAGEN     150    150       D->A: Abolishes enzymatic activity.
FT   MUTAGEN     345    345       T->A: No effect on interaction with
FT                                PPP1R8.
FT   MUTAGEN     387    387       T->A: No effect on interaction with
FT                                PPP1R8.
FT   MUTAGEN     409    409       T->A: No effect on interaction with
FT                                PPP1R8.
FT   MUTAGEN     415    415       T->A: No effect on interaction with
FT                                PPP1R8.
FT   MUTAGEN     428    428       T->A: No effect on interaction with
FT                                PPP1R8.
FT   MUTAGEN     446    446       T->A: Inhibits interaction with PPP1R8.
FT   MUTAGEN     460    460       T->A: Inhibits interaction with PPP1R8.
FT   MUTAGEN     466    466       T->A: Inhibits interaction with PPP1R8.
FT   MUTAGEN     478    478       T->A: Strongly inhibits interaction with
FT                                PPP1R8. Enhances enzymatic activity.
FT   MUTAGEN     518    518       T->A: No effect on interaction with
FT                                PPP1R8.
SQ   SEQUENCE   651 AA;  74642 MW;  57F05CDC6122E570 CRC64;
     MKDYDELLKY YELHETIGTG GFAKVKLACH ILTGEMVAIK IMDKNTLGSD LPRIKTEIEA
     LKNLRHQHIC QLYHVLETAN KIFMVLEYCP GGELFDYIIS QDRLSEEETR VVFRQIVSAV
     AYVHSQGYAH RDLKPENLLF DEYHKLKLID FGLCAKPKGN KDYHLQTCCG SLAYAAPELI
     QGKSYLGSEA DVWSMGILLY VLMCGFLPFD DDNVMALYKK IMRGKYDVPK WLSPSSILLL
     QQMLQVDPKK RISMKNLLNH PWIMQDYNYP VEWQSKNPFI HLDDDCVTEL SVHHRNNRQT
     MEDLISLWQY DHLTATYLLL LAKKARGKPV RLRLSSFSCG QASATPFTDI KSNNWSLEDV
     TASDKNYVAG LIDYDWCEDD LSTGAATPRT SQFTKYWTES NGVESKSLTP ALCRTPANKL
     KNKENVYTPK SAVKNEEYFM FPEPKTPVNK NQHKREILTT PNRYTTPSKA RNQCLKETPI
     KIPVNSTGTD KLMTGVISPE RRCRSVELDL NQAHMEETPK RKGAKVFGSL ERGLDKVITV
     LTRSKRKGSA RDGPRRLKLH YNVTTTRLVN PDQLLNEIMS ILPKKHVDFV QKGYTLKCQT
     QSDFGKVTMQ FELEVCQLQK PDVVGIRRQR LKGDAWVYKR LVEDILSSCK V
//
